Recruiting

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Sponsor:

Theratechnologies

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information